Welcome to LookChem.com Sign In|Join Free

CAS

  • or

143356-09-6

Post Buying Request

143356-09-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

143356-09-6 Usage

Chemical classification

It is a chemical compound derived from 1H-indene.

Usage in industry

Commonly used in fragrance and flavoring industry.

Applications

Used as a flavoring agent in food products, a component of perfumes and scented products, and in the production of pharmaceuticals.

Potential properties

May have potential medicinal properties.

Odor

Has a sweet, floral odor.

Usage in fragrances and flavors

Often used to add a natural, fruity note.

Future applications

May have potential applications in the development of new pharmaceuticals or other products due to its chemical properties.

Check Digit Verification of cas no

The CAS Registry Mumber 143356-09-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,3,3,5 and 6 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 143356-09:
(8*1)+(7*4)+(6*3)+(5*3)+(4*5)+(3*6)+(2*0)+(1*9)=116
116 % 10 = 6
So 143356-09-6 is a valid CAS Registry Number.

143356-09-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 2-(2,3-dihydro-1H-inden-2-yl)acetate

1.2 Other means of identification

Product number -
Other names ethyl 2-indanacetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:143356-09-6 SDS

143356-09-6Relevant articles and documents

Radical-Mediated Strategies for the Functionalization of Alkenes with Diazo Compounds

Su, Yong-Liang,Liu, Geng-Xin,Liu, Jun-Wen,Tram, Linh,Qiu, Huang,Doyle, Michael P.

supporting information, p. 13846 - 13855 (2020/09/21)

One of the most common reactions of diazo compounds with alkenes is cyclopropanation, which occurs through metal carbene or free carbene intermediates. Alternative functionalization of alkenes with diazo compounds is limited, and a methodology for the addition of the elements of Z-CHR2 (with Z = H or heteroatom, and CHR2 originates from N2 CR2) across a carbon-carbon double bond has not been reported. Here we report a novel reaction of diazo compounds utilizing a radical-mediated addition strategy to achieve difunctionalization of diverse alkenes. Diazo compounds are transformed to carbon radicals with a photocatalyst or an iron catalyst through PCET processes. The carbon radical selectively adds to diverse alkenes, delivering new carbon radical species, and then forms products through hydroalkylation by thiol-assisted hydrogen atom transfer (HAT), or forms azidoalkylation products through an iron catalytic cycle. These two processes are highly complementary, proceed under mild reaction conditions, and show high functional group tolerance. Furthermore, both transformations are successfully performed on a gram-scale, and diverse γ-amino esters, γ-amino alcohols, and complex spirolactams are easily prepared with commercially available reagents. Mechanistic studies reveal the plausible pathways that link the two processes and explain the unique advantages of each.

TRICYCLIC 1,2,4-TRIAZINE OXIDES AND COMPOSITIONS THEREFROM FOR THERAPEUTIC USE IN CANCER TREATMENTS

-

, (2008/06/13)

The invention relates to novel tricyclic 1,2,4-triazine-1-oxides and novel tricyclic 1,2,4-triazine-1,4-dioxides of formula: (I); and to related analogues, to their preparation, and to their use as hypoxia-selective drugs and radiosensitizers for cancer therapy, both alone or in combination with radiation and/or other anticancer drugs.

FUSED POLYCYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS

-

Page 15, (2008/06/13)

A novel series of amino acids of Formula (I) or a pharmaceutically acceptable salt thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 143356-09-6